These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31989033)

  • 1. Phage display as a tool for vaccine and immunotherapy development.
    Hess KL; Jewell CM
    Bioeng Transl Med; 2020 Jan; 5(1):e10142. PubMed ID: 31989033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage-based vaccines.
    Bao Q; Li X; Han G; Zhu Y; Mao C; Yang M
    Adv Drug Deliv Rev; 2019 May; 145():40-56. PubMed ID: 30594492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions.
    Ragothaman M; Yoo SY
    Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phages as delivery vehicles and phage display.
    Makky S; Abdelrahman F; Easwaran M; Safwat A; El-Shibiny A
    Prog Mol Biol Transl Sci; 2023; 201():119-132. PubMed ID: 37770167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspects of Phage-Based Vaccines for Protein and Epitope Immunization.
    Palma M
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery.
    González-Mora A; Hernández-Pérez J; Iqbal HMN; Rito-Palomares M; Benavides J
    Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32899720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phages and vaccination: towards new opportunities?].
    Margot S; Saulnier A; Barban V
    Virologie (Montrouge); 2020 Feb; 24(1):37-47. PubMed ID: 32108015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic engineering of bacteriophages: Key concepts, strategies, and applications.
    Hussain W; Yang X; Ullah M; Wang H; Aziz A; Xu F; Asif M; Ullah MW; Wang S
    Biotechnol Adv; 2023; 64():108116. PubMed ID: 36773707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophages as Potential Tools for Use in Antimicrobial Therapy and Vaccine Development.
    Zalewska-Piątek B; Piątek R
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33916345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage display as a promising approach for vaccine development.
    Aghebati-Maleki L; Bakhshinejad B; Baradaran B; Motallebnezhad M; Aghebati-Maleki A; Nickho H; Yousefi M; Majidi J
    J Biomed Sci; 2016 Sep; 23(1):66. PubMed ID: 27680328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine.
    Hashemi H; Bamdad T; Jamali A; Pouyanfard S; Mohammadi MG
    J Virol Methods; 2010 Feb; 163(2):440-4. PubMed ID: 19903497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.
    Tao P; Zhu J; Mahalingam M; Batra H; Rao VB
    Adv Drug Deliv Rev; 2019 May; 145():57-72. PubMed ID: 29981801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered M13 phage as a novel therapeutic bionanomaterial for clinical applications: From tissue regeneration to cancer therapy.
    Chang C; Guo W; Yu X; Guo C; Zhou N; Guo X; Huang RL; Li Q; Zhu Y
    Mater Today Bio; 2023 Jun; 20():100612. PubMed ID: 37063776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
    Staquicini DI; Tang FHF; Markosian C; Yao VJ; Staquicini FI; Dodero-Rojas E; Contessoto VG; Davis D; O'Brien P; Habib N; Smith TL; Bruiners N; Sidman RL; Gennaro ML; Lattime EC; Libutti SK; Whitford PC; Burley SK; Onuchic JN; Arap W; Pasqualini R
    bioRxiv; 2021 Mar; ():. PubMed ID: 33758865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial viruses as human vaccines?
    Clark JR; March JB
    Expert Rev Vaccines; 2004 Aug; 3(4):463-76. PubMed ID: 15270651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies.
    Sartorius R; D'Apice L; Prisco A; De Berardinis P
    Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31480551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propionibacterium acnes bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates.
    Marinelli LJ; Fitz-Gibbon S; Hayes C; Bowman C; Inkeles M; Loncaric A; Russell DA; Jacobs-Sera D; Cokus S; Pellegrini M; Kim J; Miller JF; Hatfull GF; Modlin RL
    mBio; 2012; 3(5):. PubMed ID: 23015740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the potential of M13 phages in biomedicine: Advancing drug nanodelivery and gene therapy.
    Fadaie M; Dianat-Moghadam H; Ghafouri E; Naderi S; Darvishali MH; Ghovvati M; Khanahmad H; Boshtam M; Makvandi P
    Environ Res; 2023 Dec; 238(Pt 1):117132. PubMed ID: 37714365
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.